Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-21, Stock:LLY, The news for the past five days is as follows:
2018-02-13: NEWS1: Dodge & Cox Comments on Eli Lilly.NEWS2: Dodge & Cox 4th Quarter Commentary.NEWS3: Health Care Sector Update for 02/13/2018: ABC,WBA,LLY,BDX,DARE.NEWS4: Health Care Sector Update for 02/13/2018: ABC,WBA,LLY,BDX,DARE.NEWS5: Health Care Sector Update for 02/13/2018: DARE,LLY,BDX.NEWS6: Health Care Sector Update for 02/13/2018: DARE,LLY,BDX.NEWS7: How Pfizer Performed Overall in 4Q17 and 2017.NEWS8: Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate.NEWS9: Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate.NEWS10: Better Buy: Eli Lilly and Company vs. Johnson & Johnson.NEWS11: Better Buy: Eli Lilly and Company vs. Johnson & Johnson.NEWS12: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2018.NEWS13: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2018.NEWS14: Health Care Sector Update for 02/13/2018: JNJ, PFE, ABT, MRK, AMGN, ABC, GNC, LLY, DARE, HCM, CLLS, BDX.NEWS15: Health Care Sector Update for 02/13/2018: JNJ, PFE, ABT, MRK, AMGN, ABC, GNC, LLY, DARE, HCM, CLLS, BDX.NEWS16: Better Buy: Eli Lilly and Company vs. Johnson & Johnson.NEWS17: Eli Lilly's Taltz meets primary endpoint in late-state trial for AS treatment.NEWS18: Lilly Announces Positive Top-Line Phase 3 Results for Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis).NEWS19: Eli Lilly: Taltz Phase 3 Study Meets Endpoints To Treat Ankylosing Spondylitis.NEWS20: Eli Lilly: Taltz Phase 3 Study Meets Endpoints To Treat Ankylosing Spondylitis.
2018-02-14: NEWS1: Merck & Co.’s Revenues in 4Q17.NEWS2: Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting.NEWS3: Lilly's Taltz Positive in Phase III Label Expansion Study.NEWS4: Lilly's Taltz Positive in Phase III Label Expansion Study.NEWS5: Merck (MRK) Halts Another Late Stage Study on Alzheimer's.NEWS6: Merck (MRK) Halts Another Late Stage Study on Alzheimer's.NEWS7: Bristol-Myers Squibb’s Valuation after Its 4Q17 Earnings.NEWS8: Merck (MRK) Halts Another Late Stage Study on Alzheimer&apos;s.NEWS9: Lilly&apos;s Taltz Positive in Phase III Label Expansion Study.NEWS10: How Did Pfizer’s Viagra and Lyrica Perform in 2017?.NEWS11: Changes in Bristol-Myers Squibb’s 4Q17 Profitability.NEWS12: Free Research Report as Eli Lilly’s Quarterly Revenue Jumped 6%; Adjusted EPS Jumped 20%.
2018-02-15: NEWS1: Keytruda’s Developments after Merck’s 4Q17 Earnings.NEWS2: How Pfizer’s Peri-LOE Products Performed in 2017.NEWS3: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS4: Merck & Co.’s Segment-Wise Performance in 4Q17.
2018-02-16: NEWS1: Can Billion-Dollar Startups Be Created From Big Companies' Unused IP? Ex-Walgreens CEO Bets 'Yes'.NEWS2: Why 2018 Could Be An 'Explosive' Year For Biotech Mergers.NEWS3: Why 2018 Could Be An 'Explosive' Year For Biotech Mergers.NEWS4: Novartis’s Cosentyx Emerged as Multi-Blockbuster Therapy in 2017.NEWS5: Here's How Eli Lilly Stock Can Regain Its Footing.NEWS6: FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments.NEWS7: FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS9: FDA Sets the Stage for Earlier-Stage Alzheimer&apos;s Treatments.
2018-02-20: NEWS1: Eli Lilly and Co (LLY) Files 10-K for the Fiscal Year Ended on December 31, 2017.NEWS2: Lilly to Participate in Cowen Health Care Conference.NEWS3: Noteworthy ETF Outflows: XLV, TMO, LLY, ANTM.NEWS4: Noteworthy ETF Outflows: XLV, TMO, LLY, ANTM.NEWS5: Health Care Sector Update for 02/20/2018: AIMT, CELG, LLY, VYGR, ABBV.NEWS6: Health Care Sector Update for 02/20/2018: AIMT, CELG, LLY, VYGR, ABBV.NEWS7: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS8: Why This Is the Best Time in Years to Buy Eli Lilly.NEWS9: Why This Is the Best Time in Years to Buy Eli Lilly.NEWS10: Survey Reveals Many People with Migraine Live with Pain Nearly Half of Every Month.NEWS11: Why This Is the Best Time in Years to Buy Eli Lilly.

Answer: Rise